Alan William Kong, MD
Ophthalmology · Palo Alto
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- Not verified
- Not the same as out of network.
- Office
- 1
Offices
1 location
Plan participation
Not verified
We could not verify current plan participation for this doctor. This does not mean they are out of network. Call Dr. Kong’s office to ask if they take your plan before you enroll.
Medicaid work
$0 in 2024
Medicaid paid $0 for 14 billed services this clinician did in 2024, up to 13 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Short return visit (20+ min) | 14 | $0 |
| 2024 | 14 | 1 | 13 | $0 |
Drugs they prescribed that Part D paid
$16,000
Pharmacies billed $16,000 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their Part D prescriptions (0 of 252) in 2024. At or below the middle of the specialty; the typical student in an organized health care education/training program clinician is at 0%.
168 generic and 84 brand-name prescriptions · $16,000 in drug cost.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Brimonidine | 55 | $7,511 | $137 |
| Rhopressa | 11 | $3,666 | $333 |
| Prednisolone Acetate | 23 | $686 | $30 |
| Dorzolamide-Timolol | 32 | $423 | $13 |
| Latanoprost | 72 | $385 | $5 |
See all 6 drugs
| Brimonidine | 55 | $7,511 | $137 |
| Rhopressa | 11 | $3,666 | $333 |
| Prednisolone Acetate | 23 | $686 | $30 |
| Dorzolamide-Timolol | 32 | $423 | $13 |
| Latanoprost | 72 | $385 | $5 |
| Timolol Maleate | 16 | $179 | $11 |
Year by year
| 2024 | 252 | 65 | 0% (0) | 33% | $16,000 |
| 2023 | 63 | 27 | 0% (0) | 37% | $5,332 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 1 drug
| Latanoprost | 20 | $275 | $14 |
Money from drug and device companies
$228 in 2025
| 2025 | 2 | 2 | None | $228 |
| 2024 | 1 | 1 | None | $114 |
| 2023 | 1 | 1 | None | $310 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Sun Pharmaceutical Industries | Cequa | $121 | 1 payment
|
| Regeneron Healthcare Solutions | Eylea Hd | $107 | 1 payment
|
See all 2 published payments
| Regeneron Healthcare Solutions | Meals · 2025-11-12 | Eylea Hd | $107 |
| Sun Pharmaceutical Industries | Meals · 2025-03-26 | Cequa | $121 |
See earlier years (2024, 2023)
2024: $114
| Abbvie | Xen Glaucoma Treatment System | $114 | 1 payment
|
2023: $310
| Alcon Vision | None | $310 | 1 payment
|
Professional record
- NPI
- 1528718053
- Trained
- University of California, San Francisco School of Medicine, 2022
- Gender
- Male
More record details
- Sole proprietor
- Yes
- Taxonomy
- Federal specialty code 207W00000X (207W00000X)
- Mailing address
- 300 Pasteur Dr, Stanford, CA, 94305
- NPI first listed
- 2022-03-27
- NPI last updated
- 2026-07-02
- NPI record certified
- 2026-07-02
This is when the NPI record was last certified, not a medical board exam.